Thor Medical is an emerging supplier of isotopes for targeted alpha therapies in oncology. Our proprietary production technology eliminates the need for nuclear reactors and cyclotrons, offering a more efficient and environmentally sustainable approach to traditional methods. By solving the supply challenges of key isotopes for the pharmaceutical market, Thor Medical is unlocking a new generation of alpha-emitting radioligand therapies for millions of cancer patients worldwide. The company is listed on the Oslo Stock Exchange under the ticker symbol TRMED.
Thor Medical is an emerging supplier of isotopes for targeted alpha therapies in oncology. Our proprietary production technology eliminates the need for nuclear reactors and cyclotrons, offering a more efficient and environmentally sustainable approach to traditional methods. By solving the supply challenges of key isotopes for the pharmaceutical market, Thor Medical is unlocking a new generation of alpha-emitting radioligand therapies for millions of cancer patients worldwide. The company is listed on the Oslo Stock Exchange under the ticker symbol TRMED.
Company Information
- Industry
- Company Type
- Public Company
- Founded
- 2009
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Kjelsåsveien 168 B Oslo
- City
- Meggen
- Region
- Lucerne
- Postal Code
- 0884
- Country
- Switzerland
